| Today's Open | $4.00 |
|---|---|
| Previous Close | $3.98 |
| Daily Range | $3.99 - $4.07 |
| 52-Week Range | $2.60 - $5.58 |
| Market Cap | $512.3M |
| P/E Ratio | -30.62 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 1,304,383 |
| Average Daily Volume | 981,380 |
| Current FY EPS | -$0.10 |
Sector
Healthcare
Industry
Healthcare Information Services
Antares Pharma, Inc. (ATRS) Description
The Company develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral fast melting tablets and reusable needle-free and disposable mini-needle injector systems. Website: http://www.antarespharma.com/
News & Commentary
3 Most Important Upcoming FDA Decisions of 2013
The Food and Drug Administration will decide on drugs developed by Merck, Antares Pharmaceuticals, and GlaxoSmithKline in the coming months.Antares Pharma Whiffs on Revenues
Just the facts, Fool.Antares Q1 Results Unimpressive, but Otrexup Could Be Catalyst
Antares Pharma didn't impress the market with its Q1 results, but a pending Food and Drug Administration decision on Otrexup might be a game changer for this small biotech.ATRS's Top Competitors
(2.01%)
(0.40%)
(0.15%)